ICD-10-PCS › X
ICD-10-PCS codes starting with X
734 codes, page 2 of 8. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| X2AL34B | Left Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 | Valid |
| X2C | New Technology, Cardiovascular System, Extirpation | Not billable |
| X2C0361 | Extirpation of Matter from Coronary Artery, One Artery using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1 through FY2021 | Retired |
| X2C1361 | Extirpation of Matter from Coronary Artery, Two Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1 through FY2021 | Retired |
| X2C2361 | Extirpation of Matter from Coronary Artery, Three Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1 through FY2021 | Retired |
| X2C3361 | Extirpation of Matter from Coronary Artery, Four or More Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1 through FY2021 | Retired |
| X2CP3T7 | Extirpation of Matter from Abdominal Aorta using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CQ3T7 | Extirpation of Matter from Right Upper Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CR3T7 | Extirpation of Matter from Left Upper Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CS3T7 | Extirpation of Matter from Right Lower Extremity Artery using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CT3T7 | Extirpation of Matter from Left Lower Extremity Artery using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CU3T7 | Extirpation of Matter from Right Lower Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CV3T7 | Extirpation of Matter from Left Lower Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2CY3T7 | Extirpation of Matter from Great Vessel using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | Valid |
| X2H | New Technology, Cardiovascular System, Insertion | Not billable |
| X2H03BB | Insertion of Volume Sensor Management Device into Inferior Vena Cava, Percutaneous Approach, New Technology Group 11 | Valid |
| X2H03R9 | Insertion of Intraluminal Device, Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9 | Valid |
| X2H13R9 | Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9 | Valid |
| X2H13XB | Insertion of Temporary Phrenic Nerve/Diaphragm Stimulation Electrodes into Superior Vena Cava, Percutaneous Approach, New Technology Group 11 | Valid |
| X2H20R9 | Insertion of Intraluminal Device, Bioprosthetic Valve into Right Femoral Vein, Open Approach, New Technology Group 9 | Valid |
| X2H30R9 | Insertion of Intraluminal Device, Bioprosthetic Valve into Left Femoral Vein, Open Approach, New Technology Group 9 | Valid |
| X2H43MC | Insertion of Temporary Intraluminal Device, Venous Angle Decompression using Impeller Pump into Left Innominate Vein, Percutaneous Approach, New Technology Group 12 | Valid |
| X2H63V9 | Insertion of Dual-Chamber Intracardiac Pacemaker into Right Atrium, Percutaneous Approach, New Technology Group 9 | Valid |
| X2HK3V9 | Insertion of Dual-Chamber Intracardiac Pacemaker into Right Ventricle, Percutaneous Approach, New Technology Group 9 | Valid |
| X2HL0F9 | Insertion of Conduit to Short-term External Heart Assist System into Right Axillary Artery, Open Approach, New Technology Group 9 | Valid |
| X2HM0F9 | Insertion of Conduit to Short-term External Heart Assist System into Left Axillary Artery, Open Approach, New Technology Group 9 | Valid |
| X2HM3GB | Insertion of Lumenless Small-diameter Defibrillator Lead into Ventricular Septum, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HN37B | Insertion of Endocardiac Pacing Electrode into Left Ventricle, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HP38B | Insertion of Temporary Intraluminal Device into Right Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HQ38B | Insertion of Temporary Intraluminal Device into Left Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HR38B | Insertion of Temporary Intraluminal Device into Right Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HS38B | Insertion of Temporary Intraluminal Device into Left Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HT38B | Insertion of Temporary Intraluminal Device into Right Peroneal Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HU38B | Insertion of Temporary Intraluminal Device into Left Peroneal Artery, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HV3GB | Insertion of Lumenless Small-diameter Defibrillator Lead into Right Ventricle, Percutaneous Approach, New Technology Group 11 | Valid |
| X2HX0F9 | Insertion of Conduit to Short-term External Heart Assist System into Thoracic Aorta, Ascending, Open Approach, New Technology Group 9 | Valid |
| X2J | New Technology, Cardiovascular System, Inspection | Not billable |
| X2JAX47 | Inspection of Heart using Transthoracic Echocardiography, Computer-aided Guidance, New Technology Group 7 | Valid |
| X2K | New Technology, Cardiovascular System, Bypass | Not billable |
| X2K00FB | Bypass Inferior Vena Cava using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11 | Valid |
| X2KA30A | Bypass Left Atrium using Conduit through Coronary Sinus to Right Atrium, Percutaneous Approach, New Technology Group 10 | Valid |
| X2KB317 | Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 through FY2026 | Retired |
| X2KC317 | Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 through FY2026 | Retired |
| X2KG0FB | Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11 | Valid |
| X2KH3D9 | Bypass Right Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9 | Valid |
| X2KH3E9 | Bypass Right Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9 | Valid |
| X2KJ3D9 | Bypass Left Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9 | Valid |
| X2KJ3E9 | Bypass Left Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9 | Valid |
| X2R | New Technology, Cardiovascular System, Replacement | Not billable |
| X2R50WA | Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 | Valid |
| X2R60WA | Replacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 | Valid |
| X2R70WA | Replacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 | Valid |
| X2R80WA | Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 | Valid |
| X2RF032 | Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Open Approach, New Technology Group 2 through FY2022 | Retired |
| X2RF332 | Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach, New Technology Group 2 through FY2022 | Retired |
| X2RF3LC | Replacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12 | Valid |
| X2RF432 | Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Endoscopic Approach, New Technology Group 2 through FY2022 | Retired |
| X2RG3FC | Replacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12 | Valid |
| X2RH0GC | Replacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12 | Valid |
| X2RJ3RA | Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10 | Valid |
| X2RX0N7 | Replacement of Thoracic Aorta, Arch using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7 | Valid |
| X2U | New Technology, Cardiovascular System, Supplement | Not billable |
| X2U4079 | Supplement Coronary Artery/Arteries with Vein Graft Extraluminal Support Device(s), Open Approach, New Technology Group 9 | Valid |
| X2U93YA | Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X2UQ0P9 | Supplement Right Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9 | Valid |
| X2UR0P9 | Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9 | Valid |
| X2V | New Technology, Cardiovascular System, Restriction | Not billable |
| X2V73Q7 | Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7 | Valid |
| X2VE3SA | Restriction of Descending Thoracic Aorta and Abdominal Aorta using Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach, New Technology Group 10 | Valid |
| X2VJ3HC | Restriction of Thoracic Aorta, Ascending and Arch using Branched Intraluminal Device, Integrated System with Innominate Branch, Percutaneous Approach, New Technology Group 12 | Valid |
| X2VW0N7 | Restriction of Thoracic Aorta, Descending using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7 | Valid |
| X2VW3JC | Restriction of Thoracic Aorta, Descending using Branched Intraluminal Device, Integrated System Extension, Percutaneous Approach, New Technology Group 12 | Valid |
| X2VX0KC | Restriction of Thoracic Aorta, Arch using Branched Intraluminal Device, with Conical Collar, Open Approach, New Technology Group 12 | Valid |
| X2VY06B | Restriction of Thoracic Aortic Arch and Descending Thoracic Aorta using Uncovered Intraluminal Device with Support Cuff, Open Approach, New Technology Group 11 | Valid |
| X9H | New Technology, Ear, Nose, Sinus, Insertion | Not billable |
| X9HD01B | Insertion of Temporary Infusion Device into Right Inner Ear, Open Approach, New Technology Group 11 | Valid |
| X9HE01B | Insertion of Temporary Infusion Device into Left Inner Ear, Open Approach, New Technology Group 11 | Valid |
| X9HF01B | Insertion of Temporary Infusion Device into Bilateral Inner Ear, Open Approach, New Technology Group 11 | Valid |
| XD2 | New Technology, Gastrointestinal System, Monitoring through FY2026 | Retired |
| XD2G4V7 | Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 through FY2026 | Retired |
| XD2G8V7 | Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 through FY2026 | Retired |
| XD2H4V7 | Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 through FY2026 | Retired |
| XD2H8V7 | Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 through FY2026 | Retired |
| XDJ | New Technology, Gastrointestinal System, Inspection | Not billable |
| XDJ07LB | Inspection of Upper Intestinal Tract using Ingestible Capsule with Light Absorption Sensor, Via Natural or Artificial Opening, New Technology Group 11 | Valid |
| XDP | New Technology, Gastrointestinal System, Irrigation | Not billable |
| XDPH8K7 | Irrigation of Lower GI using Intraoperative Single-use Oversleeve, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 | Valid |
| XEZ | New Technology, Physiological Systems and Anatomical Regions | Not billable |
| XEZ5XKC | Computer-Aided Triage and Notification for Imaging Abnormalities in Computed Tomography of Chest, Abdomen and Pelvis, New Technology Group 12 | Valid |
| XEZD3QC | Pericardial Cavity Access using Blunt-tip Concealed Needle with Mechanical Gripping Mechanism, Percutaneous Approach, New Technology Group 12 | Valid |
| XEZJ3NC | Coronary Artery Access using Image-Guided Crossing and Re-entry System, Percutaneous Approach, New Technology Group 12 | Valid |
| XEZU3HC | Computer-Aided Guidance for Intraprocedural Navigation using Ultrasound Imaging with Continuous Needle Tracking in Spinal Canal, Percutaneous Approach, New Technology Group 12 | Valid |
| XEZZXJC | High Dimensional Mixture-of-Experts Computer-aided Assessment of Inflammatory Response and Organ Function, for Notification and Triage, New Technology Group 12 | Valid |
| XEZZXLC | Computer-Aided Detection and Notification for Imaging Abnormalities in Echocardiography, New Technology Group 12 | Valid |
| XEZZXMC | Computer-Aided Detection and Notification for Abnormalities in Electrocardiogram, New Technology Group 12 | Valid |
| XEZZXPC | Cardiac Conduction Mechanism, Computer-aided Guidance for Three Dimensional Intraprocedural Navigation using Fluoroscopic Imaging, New Technology Group 12 | Valid |
| XEZZXRC | Computer-Aided Detection and Notification of Cardiac Abnormalities using Vital Signs, New Technology Group 12 | Valid |
| XEZZXSC | Cardiac Conduction Mechanism, Computer-aided Intraprocedural Visualization for Guidance, New Technology Group 12 | Valid |
| XF5 | New Technology, Hepatobiliary System and Pancreas, Destruction | Not billable |
| XF50X08 | Destruction of Liver using Ultrasound-guided Cavitation, External Approach, New Technology Group 8 | Valid |